FDAFDA · Food and drugs·Recall number D-0255-2026
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Published January 14, 2026 · Recall initiated: December 16, 2025
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- OXYCODONE AND ACETAMINOPHEN
- Manufacturer
- SpecGx, LLC
- Distributor
- Nationwide
- UPC
- 0304060522053
- Lot
- Lot: 0522J23493, expires: 03/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.